Edward A Belongia

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 38

Top Venues

Influenza and other respiratory viruses

The Journal of infectious diseases

medRxiv : the preprint server for health sciences

Human vaccines & immunotherapeutics

Marshfield Clinic Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Marshfield Clinic Research Institute

United States

Director :: Center for Clinical Epidemiology & Population Health

Publications

Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of infectious diseases 230 (1) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of infectious diseases 230 (1) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Jessica E Biddle, Huong Q Nguyen, H Keipp Talbot, Melissa A R Rolfes, Matthew Biggerstaff, Sheroi Johnson, Carrie Reed, Edward A Belongia, Carlos G Grijalva, Alexandra M Mellis
Asymptomatic and mildly symptomatic influenza virus infections by season -- Case-ascertained household transmission studies, United States, 2017-2023. medRxiv : the preprint server for health sciences (2024)
Jessica E Biddle, Huong Q Nguyen, H Keipp Talbot, Melissa A R Rolfes, Matthew Biggerstaff, Sheroi Johnson, Carrie Reed, Edward A Belongia, Carlos G Grijalva, Alexandra M Mellis
Asymptomatic and mildly symptomatic influenza virus infections by season -- Case-ascertained household transmission studies, United States, 2017-2023. medRxiv : the preprint server for health sciences (2024)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of infectious diseases 230 (1) (2024)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of infectious diseases (2024)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of infectious diseases (2024)
Jessica E Biddle, Huong Q Nguyen, H Keipp Talbot, Melissa A R Rolfes, Matthew Biggerstaff, Sheroi Johnson, Carrie Reed, Edward A Belongia, Carlos G Grijalva, Alexandra M Mellis
Asymptomatic and mildly symptomatic influenza virus infections by season -- Case-ascertained household transmission studies, United States, 2017-2023. medRxiv : the preprint server for health sciences (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of infectious diseases (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of infectious diseases (2024)
Thomas G Boyce, Min Z Levine, David L McClure, Jennifer P King, Brendan Flannery, Huong Q Nguyen, Edward A Belongia
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human vaccines & immunotherapeutics 20 (1) (2024)
Thomas G Boyce, David L McClure, Kayla E Hanson, Matthew F Daley, Malini B DeSilva, Stephanie A Irving, Lisa A Jackson, Nicola P Klein, Bruno J Lewin, Joshua T B Williams, Jonathan Duffy, Michael M McNeil, Eric S Weintraub, Edward A Belongia
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and drug safety 33 (8) (2024)
Edward A Belongia, Joshua G Petrie, Leora R Feldstein, Lizheng Guan, Peter J Halfmann, Jennifer P King, Gabriele Neumann, David Pattinson, Melissa A Rolfes, Huong Q Nguyen, Yoshihiro Kawaoka
Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection. Journal of the Pediatric Infectious Diseases Society 13 (1) (2024)
Kelsey M Sumner, Ruchi Yadav, Emma K Noble, Ryan Sandford, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Jessie R Chung, Eric Rogier, Melissa M Coughlin, Brendan Flannery
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of infectious diseases (2024)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sara Y Tartof, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and other respiratory viruses 18 (7) (2024)
Sara Y Tartof, Fagen Xie, Ruchi Yadav, Karen J Wernli, Emily T Martin, Edward A Belongia, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Natalie J Thornburg, Brendan Flannery, null null
Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and other respiratory viruses 17 (5) (2023)
Joshua G Petrie, Jennifer P King, David L McClure, Melissa A R Rolfes, Jennifer K Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A Belongia, Huong Q McLean
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza and other respiratory viruses 17 (3) (2023)
Ryan Sandford, Ruchi Yadav, Emma K Noble, Kelsey M Sumner, Devyani Joshi, Sarah C Robinson, Karen J Wernli, Emily T Martin, Manjusha Gaglani, Richard K Zimmerman, H Keipp Talbot, Carlos G Grijalva, Edward A Belongia, Christina Carlson, Melissa M Coughlin, Brendan Flannery, Bradley D Pearce, Eric Rogier
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. medRxiv : the preprint server for health sciences (2023)
Joshua G Petrie, Jennifer P King, David L McClure, Melissa A R Rolfes, Jennifer K Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A Belongia, Huong Q McLean
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza and other respiratory viruses 17 (3) (2023)
Joshua G Petrie, Jennifer P King, David L McClure, Melissa A R Rolfes, Jennifer K Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A Belongia, Huong Q McLean
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza and other respiratory viruses 17 (3) (2023)
Edward A Belongia, Joshua G Petrie, Leora R Feldstein, Lizheng Guan, Peter J Halfmann, Jennifer P King, Gabriele Neumann, David Pattinson, Melissa A Rolfes, Huong Q Nguyen, Yoshihiro Kawaoka
Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection. Journal of the Pediatric Infectious Diseases Society (2023)
Sarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, Kerry Grace Morrisey, Melissa S Stockwell, Yvonne Maldonado, Huong Q Nguyen, Katherine D Ellingson, Natalie M Bowman, Edwin Jose Asturias, Alexandra M Mellis, Sheroi Johnson, Hannah L Kirking, Melissa A R Rolfes, Vanessa Olivo, Lori Merrill, Steph Battan-Wraith, Ellen D Sano, Son H McLaren, Celibell Y Vargas, Sara Goodman, Clea C Sarnquist, Prasanthi Govindaranjan, Joshua G Petrie, Edward A Belongia, Karla Ledezma, Kathleen Pryor, Karen Lutrick, Ayla Bullock, Amy Yang, Quenla Haehnel, Suchitra Rao, Yuwei Zhu, Jonathan Schmitz, Kimberly Hart, Carlos G Grijalva, Phillip P Salvatore
Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Huong Q Nguyen, David L McClure, Jennifer P King, Jennifer K Meece, David J Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Melissa A R Rolfes, Edward A Belongia
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021. Influenza and other respiratory viruses 16 (4) (2022)
Sara S Kim, Jessie R Chung, H Keipp Talbot, Carlos G Grijalva, Karen J Wernli, Erika Kiniry, Emily T Martin, Arnold S Monto, Edward A Belongia, Huong Q McLean, Manjusha Gaglani, Mufaddal Mamawala, Mary Patricia Nowalk, Krissy Moehling Geffel, Sara Y Tartof, Ana Florea, Justin S Lee, Mark W Tenforde, Manish M Patel, Brendan Flannery, null null, Meghan L Bentz, Alex Burgin, Mark Burroughs, Morgan L Davis, Dakota Howard, Kristine Lacek, Joseph C Madden, Sarah Nobles, Jasmine Padilla, Mili Sheth
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and other respiratory viruses 16 (6) (2022)
Sara S Kim, Jessie R Chung, H Keipp Talbot, Carlos G Grijalva, Karen J Wernli, Erika Kiniry, Emily T Martin, Arnold S Monto, Edward A Belongia, Huong Q McLean, Manjusha Gaglani, Mufaddal Mamawala, Mary Patricia Nowalk, Krissy Moehling Geffel, Sara Y Tartof, Ana Florea, Justin S Lee, Mark W Tenforde, Manish M Patel, Brendan Flannery, null null, Meghan L Bentz, Alex Burgin, Mark Burroughs, Morgan L Davis, Dakota Howard, Kristine Lacek, Joseph C Madden, Sarah Nobles, Jasmine Padilla, Mili Sheth
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and other respiratory viruses 16 (6) (2022)
Sara S Kim, Jessie R Chung, H Keipp Talbot, Carlos G Grijalva, Karen J Wernli, Erika Kiniry, Emily T Martin, Arnold S Monto, Edward A Belongia, Huong Q McLean, Manjusha Gaglani, Mufaddal Mamawala, Mary Patricia Nowalk, Krissy Moehling Geffel, Sara Y Tartof, Ana Florea, Justin S Lee, Mark W Tenforde, Manish M Patel, Brendan Flannery, null null, Meghan L Bentz, Alex Burgin, Mark Burroughs, Morgan L Davis, Dakota Howard, Kristine Lacek, Joseph C Madden, Sarah Nobles, Jasmine Padilla, Mili Sheth
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and other respiratory viruses 16 (6) (2022)
Sara S Kim, Jessie R Chung, H Keipp Talbot, Carlos G Grijalva, Karen J Wernli, Erika Kiniry, Emily T Martin, Arnold S Monto, Edward A Belongia, Huong Q McLean, Manjusha Gaglani, Mufaddal Mamawala, Mary Patricia Nowalk, Krissy Moehling Geffel, Sara Y Tartof, Ana Florea, Justin S Lee, Mark W Tenforde, Manish M Patel, Brendan Flannery, null null, Meghan L Bentz, Alex Burgin, Mark Burroughs, Morgan L Davis, Dakota Howard, Kristine Lacek, Joseph C Madden, Sarah Nobles, Jasmine Padilla, Mili Sheth
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and other respiratory viruses 16 (6) (2022)
Sarah Spencer, Jessie R Chung, Edward A Belongia, Maria E Sundaram, Jennifer Meece, Laura A Coleman, Richard K Zimmerman, Mary Patricia Nowalk, Krissy Moehling Geffel, Ted M Ross, Chalise E Carter, David K Shay, Min Levine, Justine Liepkalns, Jin Hyang Kim, Suryaprakash Sambhara, Mark G Thompson, Brendan Flannery
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. Influenza and other respiratory viruses (2021)
Huong Q Nguyen, Kayla E Hanson, Allison D Foster, Scott C Olson, Sarah K Kemble, Edward A Belongia
Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018. Influenza and other respiratory viruses 14 (2) (2020)
Burney A Kieke, Edward A Belongia, David L McClure, Vivek Shinde
Prediction of serious RSV-related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons. Influenza and other respiratory viruses 14 (5) (2020)

Edward A Belongia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Edward A Belongia